{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:54:01Z","timestamp":1791474841541,"version":"4.3.4"},"reference-count":15,"publisher":"Walter de Gruyter GmbH","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_hmbci-2026-0025_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Prediabetes is a major international problem that confers an increased risk for T2DM and CVD. There is scantly data on the role of cellular inflammatory pathways in prediabetes. We investigated the relationship between prediabetes and cellular biomarkers of inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2026-0025_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included patients with prediabetes (n=47) and controls (n=55). Fasting blood samples were obtained for circulating biomarkers and monocyte isolation. Also subcutaneous adipose tissue biopsies were performed in a subgroup.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2026-0025_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Circulating biomarkers of inflammation were increased with prediabetes even following age adjustment. In monocytes there was a significant increase in TLR2 and its downstream signaling pathways including NFkB and P38 MAPkinase activity. In adipose tissue NLRP-3 inflammasome activity quantified by caspase1 was significantly increased whilst there was a trend to significance for IL-1beta. Also mast cells in AT were significantly increased.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2026-0025_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with prediabetes we present novel data supporting increased cellular pathways of inflammation in both monocytes and adipose tissue further underscoring the pro-inflammatory state of prediabetes as an important potential mechanism for the increase risk for T2DM and\u00a0CVD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/hmbci-2026-0025","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:55:29Z","timestamp":1790326529000},"source":"Crossref","is-referenced-by-count":0,"title":["Cellular pathways of inflammation in prediabetes"],"prefix":"10.1515","author":[{"given":"Beverley","family":"Adams-Huet","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences , UT Southwestern Medical Center , Dallas , TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishwarlal","family":"Jialal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (Endocrinology) and Pathology , UC Davis School of Medicine , Davis , CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"2026100815154480162_j_hmbci-2026-0025_ref_001","doi-asserted-by":"crossref","unstructured":"Unnikrishnan, R, Shaw, JE, Chan, JCN, Wild, SH, Peters, AL, Orrange, S, et al.. Prediabetes. Nat Rev Dis Primers 2025;11:49. https:\/\/doi.org\/10.1038\/s41572-025-00635-0.","DOI":"10.1038\/s41572-025-00635-0"},{"key":"2026100815154480162_j_hmbci-2026-0025_ref_002","doi-asserted-by":"crossref","unstructured":"Winter, WE, Jialal, I. Should prediabetes be classified as a treatable disease? J\u00a0Clin Med 2026;15:710. https:\/\/doi.org\/10.3390\/jcm15020710.","DOI":"10.3390\/jcm15020710"},{"key":"2026100815154480162_j_hmbci-2026-0025_ref_003","unstructured":"Luc, K, Schramm-Luc, A, Guzik, TJ, Mikolajczyk, TP. Oxidative stress and inflammatory markers in prediabetes and diabetes. J\u00a0Physiol Pharmacol 2019;70. https:\/\/doi.org\/10.26402\/jpp.2019.6.01."},{"key":"2026100815154480162_j_hmbci-2026-0025_ref_004","doi-asserted-by":"crossref","unstructured":"Grossmann, V, Schmitt, VH, Zeller, T, Panova-Noeva, M, Schulz, A, Laubert, N, et al.. Profile of the immune and inflammatory response in individuals with prediabetes and type 2 diabetes. Diabetes Care 2015;38:1356\u201364. https:\/\/doi.org\/10.2337\/dc14-3008.","DOI":"10.2337\/dc14-3008"},{"key":"2026100815154480162_j_hmbci-2026-0025_ref_005","doi-asserted-by":"crossref","unstructured":"Rajan, A, Karpagavel, L, Vidya, S, Sheena, KS, Harilal, MD, Deepthi, S, et al.. Correlation of inflammatory markers and NFATC4 gene expression among subjects with prediabetes. J\u00a0Cardiovasc Thorac Res 2024;16:264\u201374. https:\/\/doi.org\/10.34172\/jcvtr.33272.","DOI":"10.34172\/jcvtr.33272"},{"key":"2026100815154480162_j_hmbci-2026-0025_ref_006","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes. Diagnosis and classification of diabetes: standards of care in Diabetes\u00a0\u2013\u00a02026. Diabetes Care 2026;49:S27\u201349."},{"key":"2026100815154480162_j_hmbci-2026-0025_ref_007","doi-asserted-by":"crossref","unstructured":"Adams-Huet, B, Jialal, I. An increasing triglyceride-glucose index is associated with a pro-inflammatory and pro-oxidant phenotype. J\u00a0Clin Med 2024;13:3941. https:\/\/doi.org\/10.3390\/jcm13133941.","DOI":"10.3390\/jcm13133941"},{"key":"2026100815154480162_j_hmbci-2026-0025_ref_008","doi-asserted-by":"crossref","unstructured":"Jialal, I, Huet, BA, Kaur, H, Chien, A, Devaraj, S. Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care 2012;35:900\u20134. https:\/\/doi.org\/10.2337\/dc11-2375.","DOI":"10.2337\/dc11-2375"},{"key":"2026100815154480162_j_hmbci-2026-0025_ref_009","doi-asserted-by":"crossref","unstructured":"Pahwa, R, Singh, A, Adams-Huet, B, Devaraj, S, Jialal, I. Increased inflammasome activity in subcutaneous adipose tissue of patients with metabolic syndrome. Diabetes Metab Res Rev 2021;37:e3383. https:\/\/doi.org\/10.1002\/dmrr.3383.","DOI":"10.1002\/dmrr.3383"},{"key":"2026100815154480162_j_hmbci-2026-0025_ref_010","doi-asserted-by":"crossref","unstructured":"Gurung, P, Moussa, K, Adams-Huet, B, Devaraj, S, Jialal, I. Increased mast cell abundance in adipose tissue of metabolic syndrome: relevance to the proinflammatory state and increased adipose tissue fibrosis. Am J Physiol Endocrinol Metab 2019;316:E504\u20139. https:\/\/doi.org\/10.1152\/ajpendo.00462.2018.","DOI":"10.1152\/ajpendo.00462.2018"},{"key":"2026100815154480162_j_hmbci-2026-0025_ref_011","doi-asserted-by":"crossref","unstructured":"Jialal, I, Kaur, H, Devaraj, S. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. J\u00a0Clin Endocrinol Metab 2014;99:39\u201348. https:\/\/doi.org\/10.1210\/jc.2013-3092.","DOI":"10.1210\/jc.2013-3092"},{"key":"2026100815154480162_j_hmbci-2026-0025_ref_012","doi-asserted-by":"crossref","unstructured":"Jeyaraman, N, Shrivastava, S, Ravi, VR, Nallakumarasamy, A, Pundkar, A, Jeyaraman, M, et al.. Understanding and controlling the variables for stromal vascular fraction therapy. World J Stem Cells 2024;16:784\u201398. https:\/\/doi.org\/10.4252\/wjsc.v16.i8.784.","DOI":"10.4252\/wjsc.v16.i8.784"},{"key":"2026100815154480162_j_hmbci-2026-0025_ref_013","doi-asserted-by":"crossref","unstructured":"Islam, H, Jackson, GS, Boultbee, J, Tsai, SH, Moreno-Caba\u00f1as, A, Teixeira, AAS, et al.. Interleukin-10 resistance in type 2 diabetes is associated with defective STAT3 signaling in human blood leukocytes. Am J Physiol Cell Physiol 2025;328:C1293\u2013302. https:\/\/doi.org\/10.1152\/ajpcell.00124.2025.","DOI":"10.1152\/ajpcell.00124.2025"},{"key":"2026100815154480162_j_hmbci-2026-0025_ref_014","doi-asserted-by":"crossref","unstructured":"Schleh, MW, Caslin, HL, Garcia, JN, Mashayekhi, M, Srivastava, G, Bradley, AB, et al.. Metaflammation in obesity and its therapeutic targeting. Sci Transl Med 2023;15:eadf9382. https:\/\/doi.org\/10.1126\/scitranslmed.adf9382.","DOI":"10.1126\/scitranslmed.adf9382"},{"key":"2026100815154480162_j_hmbci-2026-0025_ref_015","doi-asserted-by":"crossref","unstructured":"Vazquez Arreola, E, Gong, Q, Hanson, RL, Wang, J, Sandforth, L, He, S, et al.. Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the diabetes prevention program outcome study and the DaQing diabetes prevention outcome study. Lancet Diabetes Endocrinol 2026;14:137\u201348. https:\/\/doi.org\/10.1016\/s2213-8587(25)00295-5.","DOI":"10.1016\/S2213-8587(25)00295-5"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2026-0025\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2026-0025\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:15:50Z","timestamp":1791472550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2026-0025\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":15,"alternative-id":["10.1515\/hmbci-2026-0025"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2026-0025","relation":{},"ISSN":["1868-1883","1868-1891"],"issn-type":[{"value":"1868-1883","type":"print"},{"value":"1868-1891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]}}}